Ventas, Inc. $VTR Shares Bought by Swiss National Bank

Swiss National Bank grew its holdings in shares of Ventas, Inc. (NYSE:VTR) by 10.7% during the first quarter, HoldingsChannel reports. The firm owned 1,378,568 shares of the real estate investment trust’s stock after purchasing an additional 133,200 shares during the quarter. Swiss National Bank’s holdings in Ventas were worth $112,739,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Angeles Wealth Management LLC grew its position in shares of Ventas by 4.0% in the first quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock valued at $274,000 after purchasing an additional 128 shares during the period. Bridgewater Advisors Inc. boosted its stake in Ventas by 2.0% in the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after buying an additional 133 shares during the last quarter. IHT Wealth Management LLC boosted its stake in Ventas by 3.2% in the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock worth $343,000 after buying an additional 137 shares during the last quarter. True Wealth Design LLC grew its holdings in Ventas by 32.0% in the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 138 shares during the period. Finally, Cigna Investments Inc. New increased its stake in shares of Ventas by 3.3% during the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after acquiring an additional 142 shares during the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Price Performance

VTR opened at $96.21 on Tuesday. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 52-week low of $65.15 and a 52-week high of $97.16. The company has a 50 day moving average of $87.44 and a two-hundred day moving average of $84.31. The company has a market cap of $46.77 billion, a P/E ratio of 174.93, a P/E/G ratio of 2.07 and a beta of 0.70.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the company earned $0.84 EPS. Ventas’s revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, analysts expect that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Investors of record on Tuesday, June 30th were issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.2%. The ex-dividend date was Tuesday, June 30th. Ventas’s dividend payout ratio is currently 378.18%.

Insider Buying and Selling at Ventas

In other news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the sale, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.53% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on VTR. Weiss Ratings lowered shares of Ventas from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, July 8th. BMO Capital Markets reaffirmed an “outperform” rating and set a $100.00 price target on shares of Ventas in a research report on Monday, May 4th. UBS Group increased their price target on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $100.00 price target on shares of Ventas in a report on Tuesday, June 16th. Finally, KeyCorp boosted their price objective on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $96.17.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.